These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 33950934)
21. Pharmacology of lacosamide: From its molecular mechanisms and pharmacokinetics to future therapeutic applications. Carona A; Bicker J; Silva R; Fonseca C; Falcão A; Fortuna A Life Sci; 2021 Jun; 275():119342. PubMed ID: 33713668 [TBL] [Abstract][Full Text] [Related]
22. Current understanding of the mechanism of action of the antiepileptic drug lacosamide. Rogawski MA; Tofighy A; White HS; Matagne A; Wolff C Epilepsy Res; 2015 Feb; 110():189-205. PubMed ID: 25616473 [TBL] [Abstract][Full Text] [Related]
23. Case Report: Lacosamide unmasking Shen YC; Wu JC; Lin TT; Chang KC; Su JJ; Juang JJ Front Cardiovasc Med; 2024; 11():1406614. PubMed ID: 38883985 [TBL] [Abstract][Full Text] [Related]
24. Brugada-pattern electrocardiogram in propranolol intoxication. Rennyson SL; Littmann L Am J Emerg Med; 2010 Feb; 28(2):256.e7-8. PubMed ID: 20159410 [TBL] [Abstract][Full Text] [Related]
25. Long-term safety and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy. Ben-Menachem E; Grebe HP; Terada K; Jensen L; Li T; De Backer M; Steiniger-Brach B; Gasalla T; Brock M; Biton V Epilepsia; 2019 Dec; 60(12):2437-2447. PubMed ID: 31755090 [TBL] [Abstract][Full Text] [Related]
26. [Brugada syndrome unmasked by oral flecainide in a patient with a history of supraventricular tachycardia]. Díaz-Muñoz J; García-Niebla J Semergen; 2015; 41(1):54-6. PubMed ID: 24703583 [No Abstract] [Full Text] [Related]
27. High prevalence of concealed Brugada syndrome in patients with atrioventricular nodal reentrant tachycardia. Hasdemir C; Payzin S; Kocabas U; Sahin H; Yildirim N; Alp A; Aydin M; Pfeiffer R; Burashnikov E; Wu Y; Antzelevitch C Heart Rhythm; 2015 Jul; 12(7):1584-94. PubMed ID: 25998140 [TBL] [Abstract][Full Text] [Related]
28. The Efficacy and Safety of Lacosamide for Bipolar Depression: A 12-Week Open-Label Pilot Trial. Kishi T; Nomura I; Sakuma K; Okuya M; Oya K; Iwata N J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):204-206. PubMed ID: 33666402 [No Abstract] [Full Text] [Related]
29. [Case Report on a Woman with Epilepsy Who Took Lacosamide during Pregnancy and Gave Birth to a Healthy Infant]. Kitamura S; Nishimura A; Takekuma Y; Saito Y; Umazume T; Sugawara M Yakugaku Zasshi; 2022; 142(9):1031-1035. PubMed ID: 36047215 [TBL] [Abstract][Full Text] [Related]
30. Tolerability and Safety of Lacosamide in Neonatal Population. Bamgbose O; Boyle F; Kean AC; Stefanescu BM; Wing S J Child Neurol; 2023 Mar; 38(3-4):137-141. PubMed ID: 36972493 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain. Casas-Fernández C; Martínez-Bermejo A; Rufo-Campos M; Smeyers-Durá P; Herranz-Fernández JL; Ibáñez-Micó S; Campistol-Plana J; Alarcón-Martínez H; Campos-Castelló J Drugs R D; 2012 Dec; 12(4):187-97. PubMed ID: 23193979 [TBL] [Abstract][Full Text] [Related]
33. Lacosamide Overdose: A Case of QRS Prolongation and Seizure. Ng PC; Schimmel J; Wang GS J Emerg Med; 2019 Jun; 56(6):652-656. PubMed ID: 30879851 [TBL] [Abstract][Full Text] [Related]
34. Lidocaine-induced Brugada syndrome phenotype linked to a novel double mutation in the cardiac sodium channel. Barajas-Martínez HM; Hu D; Cordeiro JM; Wu Y; Kovacs RJ; Meltser H; Kui H; Elena B; Brugada R; Antzelevitch C; Dumaine R Circ Res; 2008 Aug; 103(4):396-404. PubMed ID: 18599870 [TBL] [Abstract][Full Text] [Related]
35. Sustained ventricular tachycardia and coved-type electrocardiogram in peripheral leads: a particularly malignant phenotype of Brugada syndrome? Carinci V; Barbato G; Di Pasquale G Europace; 2014 Oct; 16(10):1507. PubMed ID: 25125570 [No Abstract] [Full Text] [Related]
36. Complete Atrioventricular Block in an Elderly Patient Treated with Low-Dose Lacosamide. Lachuer C; Corny J; Bézie Y; Ferchichi S; Durand-Gasselin B Cardiovasc Toxicol; 2018 Dec; 18(6):579-582. PubMed ID: 29948594 [TBL] [Abstract][Full Text] [Related]
37. Absence status induced by lacosamide adjunctive therapy. Ákos Szabó C; Morgan LC; Sonnenberg S; Karkar KM Epileptic Disord; 2019 Feb; 21(1):97-101. PubMed ID: 30782579 [TBL] [Abstract][Full Text] [Related]
38. Sodium-channel blocker challenge in the familial screening of Brugada syndrome: Safety and predictors of positivity. Therasse D; Sacher F; Petit B; Babuty D; Mabo P; Martins R; Jesel L; Maury P; Pasquie JL; Mansourati J; Dupuis JM; Kyndt F; Thollet A; Guyomarch B; Barc J; Schott JJ; Le Marec H; Redon R; Probst V; Gourraud JB Heart Rhythm; 2017 Oct; 14(10):1442-1448. PubMed ID: 28666944 [TBL] [Abstract][Full Text] [Related]
39. Brugada-like electrocardiographic pattern induced by lamotrigine toxicity. Strimel WJ; Woodruff A; Cheung P; Kirmani BF; Stephen Huang SK Clin Neuropharmacol; 2010; 33(5):265-7. PubMed ID: 20864838 [TBL] [Abstract][Full Text] [Related]
40. Lacosamide effectiveness and tolerability in patients with drug-resistant epilepsy and severe disability under polytherapy: Therapy optimization as emerging from an observational study. Pozzi M; Zanotta N; Epifanio R; Baldelli S; Cattaneo D; Clementi E; Zucca C Epilepsy Behav; 2022 Mar; 128():108598. PubMed ID: 35151192 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]